Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Alter, John Bigalke, Samuel Nussbaum, Lynne Powell

Progenity has appointed Jeffrey Alter, John Bigalke, Samuel Nussbaum, and Lynne Powell to its board of directors.

Alter is president of Arcturus One Consulting. He previously served as CEO of UnitedHealthcare's commercial group. Prior to that, he was senior VP of strategic financial planning for Oxford Health Plans. Before Oxford, he served as VP of finance, underwriting, and operations at Vytra Health Plans.

Bigalke is CEO of Second Half Healthcare Advisors. He is also chairman of VaxCares' advisory board and a member of Advent (formerly Adventist) Health System's advisory board. In addition, he is a senior advisor to Concord Management Services. Bigalke previously served as US national industry leader and senior partner for global healthcare and life sciences at Deloitte. Bigalke also was the firm's national director of public policy.

Nussbaum is a professor of clinical medicine at the Washington University School of Medicine. He is also a strategic consultant for EBG Advisors and a senior advisor to Sandbox Industries and the Ontario Teachers' Pension Plan. He serves on several boards, including those of Motus GI, Coherus Biosciences, and PhyMed. Prior to this, Nussbaum served as executive VP of clinical health policy and chief medical officer at Anthem. Previously, he was executive VP of medical affairs and system integration at BJC Healthcare. 

Powell serves as senior VP and chief commercial officer at BioCryst Pharmaceuticals. Prior to this, she was senior VP of North America at CSL Behring. Powell also served as the firm's VP of global commercial development and head of business development and European marketing. Prior to CSL, she held positions at Glaxo Wellcome's commercial strategy and clinical research organizations.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.